Dollars for Profs
Dig Into University Researchers' Outside Income and Conflicts of Interest
Published Dec. 6, 2019
This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.
Financial Disclosure
The University of Florida Medical School provided all outside activity disclosure data for faculty from forms filed from 2016 through June 2019. Faculty are required to report outside activities that could give rise to an appearance of conflict of interest and get approval for them.
Should you be removed from our database? Contact us at [email protected]. Read more below.
John Wingard
University of Florida, Department: Md Hematology/oncology
Should you be removed from our database? Contact us at [email protected]. Read more below.
BiolineRx
I am asked to provide advice as to clinical trial development for developing a novel CXCR4 antagonist named BL-8040 for Stem cell mobilization
mostly phone or at meeting held in conjunction with a national or international meeting; no travel expenses to be paid by sponsor at present
Filed on July 07, 2016.
Tell us what you know about John Wingard's disclosure
We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?
Other search results for: “John Wingard”
| Name | Institution | Type | Company | Disclosed Value |
|---|---|---|---|---|
| John Wingard | University of Florida | Financial Disclosure | Astellas | |
| John Wingard | University of Florida | Financial Disclosure | Penn State Cancer Institute | |
| John Wingard | University of Florida | Financial Disclosure | Viracyte | |
| John Wingard | University of Florida | Financial Disclosure | Celgene | |
| John Wingard | University of Florida | Financial Disclosure | Merck | |
| John Wingard | University of Florida | Financial Disclosure | Medical College of Wisconsin Peerview CME | |
| John Wingard | University of Florida | Financial Disclosure | Pluristem Ltd | |
| John Wingard | University of Florida | Financial Disclosure | Cidara Therapeutics | |
| John Wingard | University of Florida | Financial Disclosure | Shire Viropharma |
Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.
Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.
ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.